Charles Schwab’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-225,435
| Closed | -$7.62M | – | 3597 |
|
|
2021
Q2 | $7.62M | Buy |
225,435
+15,455
| +7% | +$522K | ﹤0.01% | 2143 |
|
|
2021
Q1 | $4.91M | Buy |
209,980
+6,019
| +3% | +$141K | ﹤0.01% | 2312 |
|
|
2020
Q4 | $5.88M | Buy |
203,961
+1,172
| +0.6% | +$33.8K | ﹤0.01% | 2140 |
|
|
2020
Q3 | $4.11M | Buy |
202,789
+137,780
| +212% | +$2.79M | ﹤0.01% | 2170 |
|
|
2020
Q2 | $1.95M | Buy |
65,009
+18,432
| +40% | +$554K | ﹤0.01% | 2438 |
|
|
2020
Q1 | $1.46M | Buy |
46,577
+7,663
| +20% | +$241K | ﹤0.01% | 2391 |
|
|
2019
Q4 | $1.83M | Buy |
38,914
+6,602
| +20% | +$311K | ﹤0.01% | 2444 |
|
|
2019
Q3 | $209K | Hold |
32,312
| – | – | ﹤0.01% | 3035 |
|
|
2019
Q2 | $397K | Hold |
32,312
| – | – | ﹤0.01% | 2917 |
|
|
2019
Q1 | $438K | Buy |
+32,312
| New | +$438K | ﹤0.01% | 2807 |
|